DI TRANA, ANNAGIULIA
DI TRANA, ANNAGIULIA
Dipartimento Scienze Biomediche e Sanita' Pubblica
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining
2022-01-01 Carlier, J.; Berardinelli, D.; Montanari, E.; Sirignano, A.; Di Trana, A.; Busardo, F. P.
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid
2020-01-01 Di Trana, A.; Mannocchi, G.; Pirani, F.; La Maida, N.; Gottardi, M.; Pichini, S.; Busardo, F. P.
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020
2021-01-01 La Maida, N.; Di Trana, A.; Giorgetti, R.; Tagliabracci, A.; Busardo, F. P.; Huestis, M. A.
Adulterants in drugs of abuse: a recent focus of a changing phenomenon
2022-01-01 Di Trana, A.; Montanari, E.
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes
2023-01-01 DI GIORGI, Alessandro; LA MAIDA, Nunzia; Taoussi, Omayema; Pichini, Simona; Paolo Busard(\`(o)), Francesco; Tini, Anastasio; DI TRANA, Annagiulia
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin
2019-01-01 Lo Faro, A. F.; Di Trana, A.; La Maida, N.; Tagliabracci, A.; Giorgetti, R.; Busardo, F. P.
Commentary: Tele-COVID-19: Does it improve the provision of health services?
2021-01-01 Di Trana, A.; Busardo, F. P.; Ricci, G.; Sirignano, A.
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy
2024-01-01 LA MAIDA, Nunzia; DI GIORGI, Alessandro; Pichini, Simona; Pellegrini, Manuela; DI TRANA, Annagiulia; Giuseppa Elmo, Maria; Marco Polselli, Gian; Casella, Pietro; Di Stefano, Adele; Ducci, Giuseppe
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis
2020-01-01 Perez-Acevedo, A. P.; Busardo, F. P.; Pacifici, R.; Mannocchi, G.; Gottardi, M.; Poyatos, L.; Papaseit, E.; Perez-Mana, C.; Martin, S.; Di Trana, A.; Pichini, S.; Farre, M.
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study
2024-01-01 Di Trana, Annagiulia; Di Giorgi, Alessandro; Sprega, Giorgia; Carlier, Jeremy; Kobidze, Giorgi; Montanari, Eva; Taoussi, Omayema; Bambagiotti, Giulia; Fede, Maria Sofia; Lo Faro, Alfredo Fabrizio; Tini, Anastasio; Busardò, Francesco Paolo; Pichini, Simona
Editorial: Drug-drug interactions in pharmacology
2023-01-01 Pichini, Simona; Di Trana, Annagiulia; García-Algar, Oscar; Busardo', Francesco Paolo
Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs
2022-01-01 Zaami, Simona; Di Trana, Annagiulia; García-Algar, Óscar; Marinelli, Enrico; Busardò, Francesco Paolo
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites
2021-01-01 Di Trana, A.; Brunetti, P.; Giorgetti, R.; Marinelli, E.; Zaami, S.; Busardo, F. P.; Carlier, J.
Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance
2019-01-01 Busardo, F. P.; Di Trana, A.; Montanari, E.; Mauloni, S.; Tagliabracci, A.; Giorgetti, R.
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches?
2022-01-01 Wille, Sarah M R; Desharnais, Brigitte; Pichini, Simona; Trana, Annagiulia Di; Busardò, Francesco Paolo; Wissenbach, Dirk K; Peters, Frank Theodor
Liquid chromatography in forensic toxicology
2023-01-01 Berardinelli, Diletta; Tini, Anastasio; Montanari, Eva; Berretta, Paolo; Di Trana, Annagiulia
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
2022-01-01 Di Trana, Annagiulia; Berardinelli, Diletta; Montanari, Eva; Berretta, Paolo; Basile, Giuseppe; Huestis, Marilyn A; Busardò, Francesco Paolo
Molecular Insights of New Psychoactive Substances (NPS) 2.0
2023-01-01 Di Trana, Annagiulia; Montana, Angelo; Lo Faro, Alfredo Fabrizio; Busardo, Francesco Paolo; Pichini, Simona
Monitoring Prenatal Exposure to Buprenorphine and Methadone
2020-01-01 Di Trana, A.; La Maida, N.; Tittarelli, R.; Huestis, M. A.; Pichini, S.; Busardo, F. P.; Carlier, J.
Profiling of in vitro metabolism of New Psychoactive Substances
2022-06-15 DI TRANA, Annagiulia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining | 1-gen-2022 | Carlier, J.; Berardinelli, D.; Montanari, E.; Sirignano, A.; Di Trana, A.; Busardo, F. P. | |
| A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid | 1-gen-2020 | Di Trana, A.; Mannocchi, G.; Pirani, F.; La Maida, N.; Gottardi, M.; Pichini, S.; Busardo, F. P. | |
| A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020 | 1-gen-2021 | La Maida, N.; Di Trana, A.; Giorgetti, R.; Tagliabracci, A.; Busardo, F. P.; Huestis, M. A. | |
| Adulterants in drugs of abuse: a recent focus of a changing phenomenon | 1-gen-2022 | Di Trana, A.; Montanari, E. | |
| Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes | 1-gen-2023 | DI GIORGI, Alessandro; LA MAIDA, Nunzia; Taoussi, Omayema; Pichini, Simona; Paolo Busard(\`(o)), Francesco; Tini, Anastasio; DI TRANA, Annagiulia | |
| Biomedical analysis of New Psychoactive Substances (NPS) of natural origin | 1-gen-2019 | Lo Faro, A. F.; Di Trana, A.; La Maida, N.; Tagliabracci, A.; Giorgetti, R.; Busardo, F. P. | |
| Commentary: Tele-COVID-19: Does it improve the provision of health services? | 1-gen-2021 | Di Trana, A.; Busardo, F. P.; Ricci, G.; Sirignano, A. | |
| Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy | 1-gen-2024 | LA MAIDA, Nunzia; DI GIORGI, Alessandro; Pichini, Simona; Pellegrini, Manuela; DI TRANA, Annagiulia; Giuseppa Elmo, Maria; Marco Polselli, Gian; Casella, Pietro; Di Stefano, Adele; Ducci, Giuseppe | |
| Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis | 1-gen-2020 | Perez-Acevedo, A. P.; Busardo, F. P.; Pacifici, R.; Mannocchi, G.; Gottardi, M.; Poyatos, L.; Papaseit, E.; Perez-Mana, C.; Martin, S.; Di Trana, A.; Pichini, S.; Farre, M. | |
| Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study | 1-gen-2024 | Di Trana, Annagiulia; Di Giorgi, Alessandro; Sprega, Giorgia; Carlier, Jeremy; Kobidze, Giorgi; Montanari, Eva; Taoussi, Omayema; Bambagiotti, Giulia; Fede, Maria Sofia; Lo Faro, Alfredo Fabrizio; Tini, Anastasio; Busardò, Francesco Paolo; Pichini, Simona | |
| Editorial: Drug-drug interactions in pharmacology | 1-gen-2023 | Pichini, Simona; Di Trana, Annagiulia; García-Algar, Oscar; Busardo', Francesco Paolo | |
| Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs | 1-gen-2022 | Zaami, Simona; Di Trana, Annagiulia; García-Algar, Óscar; Marinelli, Enrico; Busardò, Francesco Paolo | |
| In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites | 1-gen-2021 | Di Trana, A.; Brunetti, P.; Giorgetti, R.; Marinelli, E.; Zaami, S.; Busardo, F. P.; Carlier, J. | |
| Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance | 1-gen-2019 | Busardo, F. P.; Di Trana, A.; Montanari, E.; Mauloni, S.; Tagliabracci, A.; Giorgetti, R. | |
| Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? | 1-gen-2022 | Wille, Sarah M R; Desharnais, Brigitte; Pichini, Simona; Trana, Annagiulia Di; Busardò, Francesco Paolo; Wissenbach, Dirk K; Peters, Frank Theodor | |
| Liquid chromatography in forensic toxicology | 1-gen-2023 | Berardinelli, Diletta; Tini, Anastasio; Montanari, Eva; Berretta, Paolo; Di Trana, Annagiulia | |
| Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances | 1-gen-2022 | Di Trana, Annagiulia; Berardinelli, Diletta; Montanari, Eva; Berretta, Paolo; Basile, Giuseppe; Huestis, Marilyn A; Busardò, Francesco Paolo | |
| Molecular Insights of New Psychoactive Substances (NPS) 2.0 | 1-gen-2023 | Di Trana, Annagiulia; Montana, Angelo; Lo Faro, Alfredo Fabrizio; Busardo, Francesco Paolo; Pichini, Simona | |
| Monitoring Prenatal Exposure to Buprenorphine and Methadone | 1-gen-2020 | Di Trana, A.; La Maida, N.; Tittarelli, R.; Huestis, M. A.; Pichini, S.; Busardo, F. P.; Carlier, J. | |
| Profiling of in vitro metabolism of New Psychoactive Substances | 15-giu-2022 | DI TRANA, Annagiulia |